Terrace Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
as on 10-12-2024
- Paid Up Capital ₹ 5.00 M
as on 10-12-2024
- Company Age 19 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 32.75 Cr
as on 10-12-2024
- Satisfied Charges ₹ 3.00 Cr
as on 10-12-2024
- Revenue 43.11%
(FY 2022)
- Profit 71.78%
(FY 2022)
- Ebitda -8.20%
(FY 2022)
- Net Worth 4.79%
(FY 2022)
- Total Assets 14.60%
(FY 2022)
About Terrace Pharmaceuticals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 5.00 M.
The company currently has active open charges totaling ₹32.75 Cr. The company has closed loans amounting to ₹3.00 Cr, as per Ministry of Corporate Affairs (MCA) records.
Robin Chopra, Gauri Shankar, and Parveen Kumar serve as directors at the Company.
- CIN/LLPIN
U24100PB2005PTC029175
- Company No.
029175
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
11 Nov 2005
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chandigarh
Industry
Company Details
- Location
Rupnagar, Punjab, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Terrace Pharmaceuticals Private Limited offer?
Terrace Pharmaceuticals Private Limited offers a wide range of products and services, including Common Disease Medicines, Allopathic Cough Syrup, Brain & Nervous System Drugs, Antidepressant & Anti Anxiety Medicines, Antiepileptic Drugs, Antihistamines, Cardiovascular Drugs & Medication, Antianginal Drugs, Anti Infective Drugs & Medicines, Antifungal Cream, Ointment & Powder.
Who are the key members and board of directors at Terrace Pharmaceuticals?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Robin Chopra  | Director | 17-Dec-2019 | Current |
| Gauri Shankar | Director | 12-Oct-2022 | Current |
| Parveen Kumar | Director | 14-Mar-2023 | Current |
Financial Performance of Terrace Pharmaceuticals.
Terrace Pharmaceuticals Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 43.11% increase. The company also saw a substantial improvement in profitability, with a 71.78% increase in profit. The company's net worth moved up by a moderate rise of 4.79%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Terrace Pharmaceuticals?
In 2021, Terrace Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Axis Bank Limited Creation Date: 18 Oct 2023 | ₹9.95 Cr | Open |
Hdfc Bank Limited Creation Date: 03 Mar 2022 | ₹10.62 Cr | Open |
Others Creation Date: 13 Jul 2020 | ₹1.38 Cr | Open |
How Many Employees Work at Terrace Pharmaceuticals?
Terrace Pharmaceuticals has a workforce of 98 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Terrace Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Terrace Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
